drugset / Trial / NCT00402298
Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this clinical trial is to learn if MDMA-assisted therapy can treat PTSD in participants with PTSD. Researchers will compare two sessions of MDMA-assisted therapy with two sessions of low dose (active placebo) MDMA-assisted therapy to determine if MDMA-assisted therapy is safe and works to treat PTSD symptoms. Participants will be randomly assigned to receive either the full dose of MDMA or low active placebo dose of MDMA during each of two experimental sessions. PTSD symptoms will be measured throughout the study.
Timeline
- Start
- 2007-05-27
- Primary completion
- 2009-03
- Completion
- 2010-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midomafetamine | Unknown | 25 mg | Oral |
| Subject | Midomafetamine | Unknown | 125 mg | Oral |